Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-2-7
pubmed:abstractText
Antiphospholipid antibody syndrome (APAS) is regarded as the most frequently acquired risk factor for thrombophilia. The obstetric manifestations of APAS include early or late pregnancy losses and complications like preeclampsia and fetal growth restriction. Its timely diagnosis and treatment can improve maternal and neonatal outcome. Aims: To study the pregnancy outcome of patients with APAS treated with heparin and aspirin.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0022-3859
pubmed:author
pubmed:issnType
Print
pubmed:volume
57
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
16-9
pubmed:meshHeading
pubmed-meshheading:21206127-Adult, pubmed-meshheading:21206127-Antiphospholipid Syndrome, pubmed-meshheading:21206127-Aspirin, pubmed-meshheading:21206127-Birth Rate, pubmed-meshheading:21206127-Cohort Studies, pubmed-meshheading:21206127-Female, pubmed-meshheading:21206127-Fetal Growth Retardation, pubmed-meshheading:21206127-Fibrinolytic Agents, pubmed-meshheading:21206127-Gestational Age, pubmed-meshheading:21206127-Heparin, pubmed-meshheading:21206127-Hospitals, Teaching, pubmed-meshheading:21206127-Humans, pubmed-meshheading:21206127-India, pubmed-meshheading:21206127-Pregnancy, pubmed-meshheading:21206127-Pregnancy Complications, pubmed-meshheading:21206127-Pregnancy Outcome, pubmed-meshheading:21206127-Retrospective Studies, pubmed-meshheading:21206127-Treatment Outcome, pubmed-meshheading:21206127-Young Adult
pubmed:articleTitle
The obstetric outcome following treatment in a cohort of patients with antiphospholipid antibody syndrome in a tertiary care center.
pubmed:affiliation
Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India. vatslad@hotmail.com
pubmed:publicationType
Journal Article